Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 4/20 | 0.68 |
| ▸ | HPGD | P15428 | 4/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.68 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 2/20 | 0.68 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.68 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.68 |
| ▸ | IDO1 | P14902 | 1/20 | 0.68 |
| ▸ | CASP1 | P29466 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL574407 | 0.96 | HIF1A (0.63) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| SCHEMBL6915416 | 0.90 | MEN1 (0.57) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| SCHEMBL5269987 | 0.90 | HIF1A (0.57) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| Diethylamine SCHEMBL16098374 | 0.90 | HIF1A (0.57) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| 2-Chlorophenol SCHEMBL5085978 | 0.87 | CYP3A4 (0.53) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| SCHEMBL7858971 | 0.83 | MEN1 (0.49) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| SCHEMBL29810184 | 0.83 | HIF1A (0.63) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| SCHEMBL630770 | 0.83 | HIF1A (0.63) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| Dichlorophen SCHEMBL2453304 | 0.83 | CYP3A4 (0.83) | HIF1AHPGDALOX15MEN1CYP3A4 | |
| SCHEMBL1005910 | 0.82 | HSD17B10 (0.50) | HIF1AHPGDALOX15MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| WO-2012170841-A1 | AN AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2012-12-13 | — | — | WO | claimed |
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| US-20090214606-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | CIBA SPECIALTY CHEMICALS CORP. | 2009-08-27 | — | — | US | claimed |
| EP-1549731-B1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2008-12-17 | — | — | EP | claimed |
| US-20060142184-A1 | Protein based oral lubricant | PACIFIC BIOLINK PTY LIMITED (AU) | 2006-06-29 | — | — | US | claimed |
| US-20060093570-A1 | Surface treatment | RECKITT BENCKISER (UK) LIMITED (GB) | 2006-05-04 | — | — | US | claimed |
| US-20060040847-A1 | Hard surface treating compositions | RECKITT BENCKISER INC. | 2006-02-23 | — | — | US | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| WO-2004035724-A1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2004035723-A1 | DISINFECTANT CLEANING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2004024861-A1 | HARD SURFACE TREATING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2004-03-25 | — | — | WO | claimed |
| WO-2004000252-A1 | PROTEIN BASED ORAL LUBRICANT | PACIFIC BIOLINK PTY LIMITED (AU) | 2003-12-31 | — | — | WO | claimed |
| US-6652875-B1 | Complexed with calcium phosphate | PACIFIC BIOLINK PTY. LIMITED (AU) | 2003-11-25 | — | — | US | claimed |
| US-20030206939-A1 | Casein formulations for the delivery of bioactive constituents | PACIFIC BIOLINK PTY. LIMITED | 2003-11-06 | — | — | US | claimed |
| EP-1098628-A1 | CASEIN FORMULATIONS FOR THE DELIVERY OF BIOACTIVE CONSTITUENTS | Pacific Biolink PTY. Limited (AU) | 2001-05-16 | — | — | EP | claimed |
| WO-2000006108-A1 | CASEIN FORMULATIONS FOR THE DELIVERY OF BIOACTIVE CONSTITUENTS | PACIFIC BIOLINK PTY. LIMITED (AU) | 2000-02-10 | — | — | WO | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | HIF1A 1235/4885HPGD 623/4885ALOX15 903/4885 |
| US-20090214606-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | ORAI3, PRF1, THPO | HIF1A 1249/4885HPGD 4414/4885ALOX15 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.